- BusinessBusiness Insider•7 hours ago
The pharmaceutical company Mylan, which makes the EpiPen, is now saying it understated the profits it derives from the life-saving allergy drug by 60% in a congressional hearing last week, according to The Wall Street Journal. Mylan paid a 7.4% tax rate last year after moving its business to The Netherlands for tax purposes. The company's CEO, Heather Bresch, was called to the House of Representatives to answer for why her company had raised the EpiPen's price by 500% since it purchased the drug in 2007.
- TMUSZacks•11 hours ago
Leading U.S. national wireless carrier T-Mobile US Inc. TMUS recently entered into an agreement with cable MSO (multi service operator) Charter Communications Inc. CHTR to acquire a license of 700 MHz A Block spectrum for Eastern Montana from the latter
- financeEthan Wolff-Mann•4 hours ago
With more than 2 million accounts and credit cards opened without permission, Wells Fargo (WFC) has a lot of work to do to mend fences with the public. Are you a Wells Fargo customer who was impacted by the unauthorized accounts?